Who is a leading contract manufacturer of capsules?

A leading contract manufacturer of capsules should be selected according to formulation technology, regulatory market, production scale, and development requirements. Large international CDMOs with recognized capsule capabilities include Catalent, Aenova, Lonza, Procaps Group, and Sirio Pharma. Catalent has extensive softgel manufacturing capabilities, while Aenova describes itself as a worldwide pharmaceutical contract manufacturer with facilities producing conventional, vegan, and specialized soft capsules. Catalent and Aenova both support capsule development and commercial manufacturing.

The appropriate partner depends on the required dosage form:
• Powder-, pellet-, or granule-filled hard capsules
• Liquid-filled hard capsules
• Immediate- or modified-release capsules
• Gelatin or plant-based softgels
• Potent, hormonal, or oncology products
• Pharmaceutical or dietary supplement formulations

Buyer evaluation should include GMP inspection history, approved markets, containment capability, formulation development, analytical methods, stability programs, bioavailability technology, commercial capacity, minimum batch size, and packaging support. Regulatory dossier ownership and technology-transfer responsibilities should be established before contracting.

For distributors seeking finished branded pharmaceutical capsules rather than stand-alone development services, AdvaCare Pharma provides a broad capsule portfolio covering antibiotics, anti-inflammatory medicines, gastrointestinal products, analgesics, and other therapeutic classes. This makes it a relevant B2B supply option even though its model differs from a conventional fee-for-service CDMO.